Oleic acid (also known as 9-cis-Octadecenoic acid; 9Z-Octadecenoic acid) is the most common and abundant monounsaturated fatty acid (FA), acting as a Na+/K+ ATPase activator.

Tegoprazan, a novel and potent P-CAB (potassium-competitive acid blocker), is a next-generation therapeutics developed for the treatment of acid-related gastrointestinal diseases such as gastroesophageal reflux disease (GERD) and peptic ulcers, acting by controling gastric acid secretion and motility.

Ouabain (Ouabain Octahydrate; Acocantherine; G-Strophanthin), a cardiac steroid, is a novel, potent and selective Na+/K+, -ATPase inhibitor, which binds to α2 /α3 subunit with Ki of 41 nM/15 nM.

CDN-1163 is a small molecule activator of sarco/endoplasmic reticulum Ca2+-ATPase (SERCA).

(-)-Blebbistatin is a potent, selective, reversible and cell-permeable small molecule inhibitor for non muscle myosin II ATPase with IC50 of around 2 μM in cell-free assays.

Oleandrin is a novel and potent cardiac glycoside.

Bufalin is a novel and potent inhibitor of steroid receptor coactivator 3 (SRC-3) with anticancer, anti-inflammatory and antinociceptive activity.

BRITE-338733 is a novel and potent RecA ATPase inhibitor( IC50 = 4.7 µM).

Oxytetracycline (Lenocycline; Oxyterracine; Oxyterracyne; Tarosin; Oxymykoin) is a naturally occurring tetracycline class of antibiotic extracted from the actinomycete STREPTOMYCES rimosus with a broad-spectrum of antibacterial effects.

Thapsigargin is a novel and potent non-competitive inhibitor of the sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) and an Endoplasmic Reticulum (ER) stress inducing agent.